Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes. - Wikidata - awgldk - TriplyDB

Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.

Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.

http://www.wikidata.org/entity/Q33998649

about

The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling.Readers, writers, and erasers: chromatin as the whiteboard of heart disease Non-sirtuin histone deacetylases in the control of cardiac aging Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.Mesenchymal stem cell-derived inflammatory fibroblasts promote monocyte transition into myeloid fibroblasts via an IL-6-dependent mechanism in the aging mouse heart.NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4 MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification.Role of Circulating Fibrocytes in Cardiac Fibrosis Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars.Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats.Circulating fibrocytes serve as a marker for clinical diagnosis.Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction.Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD.Mesenchymal stem cell-derived inflammatory fibroblasts mediate interstitial fibrosis in the aging heart.Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation.Histone deacetylase adaptation in single ventricle heart disease and a young animal model of right ventricular hypertrophy.Epigenetic regulation of cardiac fibrosis.The potential of targeting epigenetic regulators for the treatment of fibrotic cardiac diseases.Persistent change in cardiac fibroblast physiology after transient ACE inhibition.Epigenetic factors as drivers of fibrosis in systemic sclerosis.Histone Demethylation and Toll-like Receptor 8-Dependent Cross-Talk in Monocytes Promotes Transdifferentiation of Fibroblasts in Systemic Sclerosis Via Fra-2.Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferation.New Aspects of Vascular Calcification: Histone Deacetylases and Beyond.Class I HDACs control a JIP1-dependent pathway for kinesin-microtubule binding in cardiomyocytes.Long noncoding RNA: a new contributor and potential therapeutic target in fibrosis.Epigenetics for the pediatric cardiologist.A grape seed procyanidin extract inhibits HDAC activity leading to increased Pparα phosphorylation and target-gene expression.Resident fibroblast expansion during cardiac growth and remodeling.Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts.Epigenetic Modulation of Collagen 1A1: Therapeutic Implications in Fibrosis and Endometriosis.Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis.Epigenetic Regulation of Myofibroblast Phenotypes in Fibrosis The effect of melatonin on cardio fibrosis in juvenile rats with pressure overload and deregulation of HDACs Obesity-mediated regulation of cardiac protein acetylation: parallel analysis of total and acetylated proteins via TMT-tagged mass spectrometry Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure miR-133: A Suppressor of Cardiac Remodeling?

P2860

Q28075539-09EE3690-FA67-4F33-AEA5-4CAE14EE19EF Q28084598-5ED522D7-E9B9-472C-B46E-93A180217564 Q33891516-C34E705E-45C6-436E-9317-AD8EE768A25F Q33913127-818BDFFF-623E-407E-8AD6-80FD1AA4AF64 Q35234488-40EC6D15-2E84-49F0-9C5C-CC9C78936817 Q35695849-EA979DCD-23FC-4A58-A5C0-F5DE8DF7A801 Q35723859-1EC267F3-264B-4C26-A476-9F5EF6DD7852 Q35878968-9AEE9A1F-CFA8-4359-8620-0407EBE64C47 Q36339460-BB300680-F172-480E-9D09-9BE25DE8D8D0 Q36541232-CF935880-AD15-44B8-ABF1-F0ECD8E8B51D Q36705598-104C565A-8023-49C4-A573-5D4A7125F996 Q36830137-8A1549B8-E0B4-4445-8936-837971E40559 Q37239770-C3BF8AB0-63D8-4A16-B0D3-B4B2344F9815 Q37407841-E77B8A48-411D-437A-9A50-B73D6B7C6BEB Q38196176-4899DDB2-F9A7-436F-B83D-808A5C878403 Q38246170-987911CF-9B07-4C42-898A-259AB414E1BD Q38341214-190A4F18-321F-40B3-99CA-6BE87A9F495B Q38604069-884BBC96-A90D-4B72-B25B-F46BE177DF7C Q38662343-161A26CC-ADCA-446E-92F7-2C4DDF2827E9 Q38678462-35C25429-61D2-4F39-9B59-807268517990 Q38733315-C0171281-9BEA-4C37-A26E-797F09658C36 Q38828267-C28A70D2-6BF4-499D-B766-314B06E9ED36 Q38963920-822C2884-71BF-4367-BCF8-9CBB80DED0E9 Q39200920-AB4D0199-0260-4A13-8093-DE20250F723B Q40057489-27B3DEC8-D086-4729-901D-788363289CD5 Q42494392-2F684484-DA2F-4791-80D1-BF234284574D Q42702677-300F0C23-C4F4-4965-A723-BA38F50168C7 Q47832574-E18BF57F-D129-4169-A5DF-A71B1B40A29F Q47951358-5761D0F4-28EA-4DED-836D-64B1D318B957 Q48233679-30DC05B7-1520-40CC-ADCD-C19A2A3F84FB Q49513722-30AFFE8C-E9C1-4B63-9A84-474452922007 Q50204070-27E6644A-852B-4F8C-8F5A-896532573EED Q52793543-A5E9C744-5BC7-4CD3-960C-1D19EF51C395 Q52882350-5FDFEB2B-AD10-4049-9E0C-33D7680C5890 Q54990315-F8C2D158-1C01-46E8-B313-623F7B1A45B3 Q57147732-C705C3C3-34A0-4954-9A64-8B93516E3944 Q58565291-0C26513E-81FB-4975-92C9-131FB9EFCE6F Q58760378-EE8D94F7-11BA-413C-9563-4B819A4D6ECE Q58766782-A4EE2CF2-847D-4F8C-8B5C-02928BEDB031 Q58769694-B89794AF-C068-43F0-9B9D-FDE939054DA0

P2860

Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.

http://www.wikidata.org/entity/Q33998649

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Class I HDACs regulate angiote ...... ts and circulating fibrocytes.

@ast

Class I HDACs regulate angiote ...... ts and circulating fibrocytes.

@en

type

label

Class I HDACs regulate angiote ...... ts and circulating fibrocytes.

@ast

Class I HDACs regulate angiote ...... ts and circulating fibrocytes.

@en

prefLabel

Class I HDACs regulate angiote ...... ts and circulating fibrocytes.

@ast

Class I HDACs regulate angiote ...... ts and circulating fibrocytes.

@en

P1433

Q33998649-2F61DB30-57F4-496A-93E2-CF1B81819A5A

P1476

Q33998649-9077107F-7316-41C5-A963-0CD6DDCC2280

P2093

Q33998649-23E03206-95D8-4A75-ADD5-0AED3620F2B0

Q33998649-2B1FB397-7DE0-4BA8-B21C-B32205DD45EA

Q33998649-6CEB2DF2-0F79-4134-BB81-5B732DE8E5BC

Q33998649-888AA7BD-8FF7-4090-9F0D-20D0601D08A1

Q33998649-CD29BCFD-DB59-4CF1-BB69-C310B1237ACE

Q33998649-D6D30D78-F409-4414-9B55-0212FB7FD7EF

Q33998649-E3BE7D73-0793-4E58-B3F4-3CC3BC018725

P2860

Q33998649-02542090-6AC0-4005-8F3D-64071D589597

Q33998649-075F2059-C733-4049-965B-BF312DA2F6B4

Q33998649-089BB6CA-D15D-4879-9968-7391599F153B

Q33998649-0C87147D-F184-423A-AA19-636978A0E2CF

Q33998649-0CCAC2D8-2431-4032-81B2-5B29AF8B5DDB

Q33998649-16CDBD77-AC94-48E8-B84C-AE204432C85E

Q33998649-1B713DF6-3CAA-44B6-A06F-29C2B1A8F4EF

Q33998649-1F719506-2739-4DA4-94F8-D963CECAD45F

Q33998649-45BAB06A-342A-4277-8FE4-81A3119C1E20

Q33998649-45F9D863-2D2B-4A4A-A550-8D146C32C34A

P304

Q33998649-8E2A26A7-2817-4FEE-8FD1-90A160357E51

P31

Q33998649-ABD1C1D1-2B90-4EA4-B936-00AFC2B36827

P356

Q33998649-70F06E3C-D280-47CB-91E9-6866FA497DE6

P478

Q33998649-688B6162-5594-4F60-AB55-E19FF5C74331

P50

Q33998649-03a53f86-43b9-d0ea-09aa-9b1e7c42dabe

Q33998649-2FCC1AFF-93FE-4C9F-8268-34680FA68C98

P577

Q33998649-C8E9E666-CC48-48AE-AEE5-FF986AA35C0A

P5875

Q33998649-C18A9CAF-804C-4D11-82D7-491DED3F99B0

P698

Q33998649-5A06F09C-1F51-40C3-ADE7-016544FE49F1

P932

Q33998649-90D7EAB2-60E1-4C76-86E6-C7EBA8FBBC68

P356

J.YJMCC.2013.12.013

P1433

Journal of Molecular and Cellular Cardiology

P1476

Class I HDACs regulate angiote ...... ts and circulating fibrocytes.

@en

P2093

Katherine B Schuetze

http://www.w3.org/2001/XMLSchema#string

Kim Demos-Davies

http://www.w3.org/2001/XMLSchema#string

Kurt R Stenmark

http://www.w3.org/2001/XMLSchema#string

Maria A Cavasin

http://www.w3.org/2001/XMLSchema#string

Michael E Yeager

http://www.w3.org/2001/XMLSchema#string

Sarah M Williams

http://www.w3.org/2001/XMLSchema#string

Timothy A McKinsey

http://www.w3.org/2001/XMLSchema#string

P2860

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

Trends in prevalence and outcome of heart failure with preserved ejection fraction

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

Elevated circulating fibrocyte levels in patients with hypertensive heart disease.

Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart

A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.

Isoform-selective HDAC inhibitors: closing in on translational medicine for the heart.

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs.

Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.

P304

112-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YJMCC.2013.12.013

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

Bradley S. Ferguson

Lucy Golden-Mason

P577

2013-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259490453

http://www.w3.org/2001/XMLSchema#string

P698

24374140

http://www.w3.org/2001/XMLSchema#string

P932

4120952

http://www.w3.org/2001/XMLSchema#string